Literature DB >> 26629220

Impact of different surgical traumas on postoperative ileus in rats and the mechanisms involved.

Cheng-Le Zhuang1, Fan-Feng Chen1, Jin-Xiao Lu1, Bei-Shi Zheng1, Shu Liu1, Chong-Jun Zhou1, Dong-Dong Huang1, Xian Shen1, Zhen Yu2.   

Abstract

The degree of postoperative ileus and the underlying pathophysiological mechanism among different types of surgical traumas have not been examined. The aim of this study was to investigate the inflammatory and oxidative stress changes in rat intestinal muscularis and gastrointestinal transit among three types of surgical traumas. Rats were randomized assigned to four groups: control group, intestinal manipulation (IM) group, intestinal ischemia/reperfusion injury (IR) group and peritoneal air exposure (AE) group. Gastrointestinal transit was measured 24 hours after surgery. Malondialdehyde (MDA), glutathione (GSH) and inflammatory mediators in intestinal muscularis were measured. Influx of neutrophil in intestinal muscularis was also determined. The degree of gastrointestinal motility impairment was equal between the IM and AE groups. However, the IR group was subject to a less impairment of gastrointestinal motility compared with the IM and AE groups. The IM group showed the most significant increase of inflammatory response, while the AE group showed the most significant increase of oxidative stress. The IR group showed a moderate increase of inflammatory response and oxidative stress. Rats subjected to IM, IR and AE could all develop into POI. We speculate that oxidative stress should be an equally important pathophysiological mechanism of POI as inflammation.

Entities:  

Keywords:  Postoperative ileus; inflammation; oxidative stress; surgical trauma

Year:  2015        PMID: 26629220      PMCID: PMC4659108     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  21 in total

1.  Safety and efficacy of methylnaltrexone in shortening the duration of postoperative ileus following segmental colectomy: results of two randomized, placebo-controlled phase 3 trials.

Authors:  Chang Sik Yu; Ho-Kyung Chun; Nancy Stambler; Jennifer Carpenito; Seth Schulman; Evan Tzanis; Bruce Randazzo
Journal:  Dis Colon Rectum       Date:  2011-05       Impact factor: 4.585

2.  Intestinal inflammation in postoperative ileus: pathogenesis and therapeutic targets.

Authors:  Jakub Rychter; Pere Clavé
Journal:  Gut       Date:  2013-02-08       Impact factor: 23.059

3.  Gastric motor effects of peptide and non-peptide ghrelin agonists in mice in vivo and in vitro.

Authors:  T Kitazawa; B De Smet; K Verbeke; I Depoortere; T L Peeters
Journal:  Gut       Date:  2005-04-20       Impact factor: 23.059

4.  N-3 PUFAs attenuate ischemia/reperfusion induced intestinal barrier injury by activating I-FABP-PPARγ pathway.

Authors:  Xinying Wang; Liya Pan; Jun Lu; Ning Li; Jieshou Li
Journal:  Clin Nutr       Date:  2012-05-02       Impact factor: 7.324

5.  Ghrelin/motilin-related peptide is a potent prokinetic to reverse gastric postoperative ileus in rat.

Authors:  L Trudel; C Tomasetto; M C Rio; M Bouin; V Plourde; P Eberling; P Poitras
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2002-06       Impact factor: 4.052

6.  The Ghrelin agonist TZP-101 for management of postoperative ileus after partial colectomy: a randomized, dose-ranging, placebo-controlled clinical trial.

Authors:  Irinel Popescu; Phillip R Fleshner; John C Pezzullo; Philippa A Charlton; Gordana Kosutic; Anthony J Senagore
Journal:  Dis Colon Rectum       Date:  2010-02       Impact factor: 4.585

7.  Effect of the ghrelin receptor agonist TZP-101 on colonic transit in a rat model of postoperative ileus.

Authors:  Graeme L Fraser; Kalina Venkova; Hamid R Hoveyda; Helmut Thomas; Beverley Greenwood-Van Meerveld
Journal:  Eur J Pharmacol       Date:  2008-12-14       Impact factor: 4.432

8.  Safety and efficacy of ulimorelin administered postoperatively to accelerate recovery of gastrointestinal motility following partial bowel resection: results of two randomized, placebo-controlled phase 3 trials.

Authors:  Monica Shaw; Claudio Pediconi; Donna McVey; Elsa Mondou; Joe Quinn; Beth Chamblin; Franck Rousseau
Journal:  Dis Colon Rectum       Date:  2013-07       Impact factor: 4.585

9.  Ginsenoside Rb1 improves postoperative fatigue syndrome by reducing skeletal muscle oxidative stress through activation of the PI3K/Akt/Nrf2 pathway in aged rats.

Authors:  Cheng-Le Zhuang; Xiang-Yu Mao; Shu Liu; Wei-Zhe Chen; Dong-Dong Huang; Chang-Jing Zhang; Bi-Cheng Chen; Xian Shen; Zhen Yu
Journal:  Eur J Pharmacol       Date:  2014-06-27       Impact factor: 4.432

Review 10.  Pharmacological and clinical aspects of heme oxygenase.

Authors:  Nader G Abraham; Attallah Kappas
Journal:  Pharmacol Rev       Date:  2008-03-06       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.